Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Surgery for Oligometastatic Non-Small Cell Lung Cancer
The bioavailability problem: what happens to oral GLP-1 agonists in the digestive system Bioavailability measures the percentage of an administered dose that reaches systemic circulation unchanged
Past performance does not guarantee future results
Abstract Immune-checkpoint inhibitors (ICIs) have transformed patient care in oncology but are associated with a unique spectrum of organ-specific inflammatory toxicities known as immune-related adverse events (irAEs)
US$ 20.30
US$ 22.73
US$ 22.16
US$ 29.16
US$ 25.81
